Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results…
